Ms. Rieger joined Achillion in May 2013 as Senior Director Medical and Regulatory Writing and was promoted to Vice President Portfolio Management in early 2014. She brings over 30 years of drug development experience in several therapeutic areas from Pfizer, Warner-Lambert/Parke-Davis, inVentiv Health Clinical, Boehringer-Ingelheim, Ayerst Laboratories, University of Rochester, and G.D. Searle. While at Pfizer, she was most recently a Portfolio Director for the Inflammation, Dermatology, and Pain therapeutic areas working with the research, development, and commercial business unit heads to implement strategic plans and optimize project delivery. She had previously led a project planning and performance function for clinical studies, had led a development operations team leader function for clinical studies, and had served as the global operations team leader for cardiovascular programs including atorvastatin. She led medical writing departments at Warner-Lambert/Parke Davis and inVentiv Health Clinical and contributed to numerous successful regulatory filings and marketing approvals. Ms. Rieger holds a BS in Biology and Chemistry from Valparaiso University and an MBA from Loyola University Chicago.